(Q72848817)
Statements
Human recombinant interferon alpha-2a (r IFN alpha-2a) therapy suppresses hepatic triglyceride lipase, leading to severe hypertriglyceridemia in a diabetic patient (English)
S Yamagishi
T Abe
1 December 1994
scientific article published on 01 December 1994